Wordt geladen...
Biosimilars in the United States: Considerations for Oncology Advanced Practitioners
Biosimilars will enter the US market soon, potentially lowering costs and increasing patient access to important oncology biologics. Biosimilars are highly similar, but not identical, to their reference product. Subtle variations arise due to their inherent complexity and differences in manufacturin...
Bewaard in:
| Gepubliceerd in: | J Adv Pract Oncol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Harborside Press
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4601891/ https://ncbi.nlm.nih.gov/pubmed/26649244 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|